Sign Up
Stories
Bio-Innovation Combats Iron Deficiency
Share
Arla Foods: Expansion and Sustainability...
Dairy Industry Trends and Relief Program...
European Biotech Startups Revolutionize ...
Advancements in Alternative Proteins
Agtech Resilience Amid Capital Decline
Animal Health Portfolio Acquisition Deal
Overview
API
Swedish startup Ironic Biotech secures €1 million pre-seed funding to combat global iron deficiency and anemia crises by developing plant-derived proteins with high bioavailability. The company targets 2 billion affected individuals, focusing on empowering women and providing side-effect-free solutions.
Ask a question
How does the bioavailability of plant-derived proteins contribute to combating iron deficiency more effectively than traditional supplements?
How might the success of Ironic Biotech impact the future of plant-based protein innovation and its integration into the food industry?
What specific challenges do women face regarding iron deficiency, and how does Ironic Biotech aim to address these challenges?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Jan 2024
Feb 2024
Mar 2024
Apr 2024
Coverage